Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 22.0 (21.9, 22.1) N/A 86,932 59.9
Wyoming 2 22.8 (21.2, 24.5) 22 (7, 39) 159 63.1
Wisconsin 2 21.7 (21.2, 22.2) 31 (23, 35) 1,564 61.8
West Virginia 2 27.5 (26.5, 28.4) 2 (1, 4) 677 61.5
Washington 1 21.0 (20.6, 21.5) 33 (29, 39) 1,836 61.9
Virginia 2 20.4 (20.0, 20.8) 38 (33, 43) 2,062 60.3
Vermont 2 17.9 (16.6, 19.3) 49 (41, 51) 155 56.3
Utah 7 17.9 (17.2, 18.6) 51 (47, 51) 517 60.3
Texas 7 23.3 (23.0, 23.5) 18 (14, 22) 6,995 61.0
Tennessee 2 24.3 (23.8, 24.7) 11 (7, 16) 2,013 62.6
South Dakota 2 25.3 (23.9, 26.8) 7 (2, 19) 268 63.9
South Carolina 2 22.8 (22.3, 23.3) 21 (15, 28) 1,459 63.0
Rhode Island 2 20.1 (19.0, 21.2) 40 (28, 48) 277 62.1
Puerto Rico 2 18.2 (17.7, 18.8) N/A 855 49.4
Pennsylvania 2 23.4 (23.0, 23.7) 17 (13, 22) 3,958 62.8
Oregon 2 20.1 (19.5, 20.6) 41 (34, 46) 1,039 61.9
Oklahoma 2 24.1 (23.5, 24.8) 12 (7, 19) 1,096 59.1
Ohio 2 23.8 (23.4, 24.1) 14 (10, 19) 3,476 61.7
North Dakota 2 23.7 (22.2, 25.2) 15 (4, 31) 206 61.0
North Carolina 2 22.5 (22.1, 22.9) 23 (19, 28) 2,804 63.1
New York 7 20.3 (20.0, 20.6) 39 (35, 43) 5,002 56.7
New Mexico 7 18.6 (17.9, 19.4) 48 (42, 51) 485 56.1
New Jersey 7 22.0 (21.6, 22.4) 27 (22, 32) 2,519 57.5
New Hampshire 2 20.9 (20.0, 22.0) 34 (23, 44) 382 60.9
Nevada 2 19.8 (19.2, 20.5) 42 (34, 48) 730 57.0
Nebraska 2 22.5 (21.6, 23.4) 24 (14, 33) 507 58.3
Montana 2 22.8 (21.7, 24.1) 20 (10, 34) 318 62.3
Missouri 2 25.6 (25.1, 26.1) 5 (4, 9) 1,924 63.4
Mississippi 2 28.9 (28.1, 29.7) 1 (1, 2) 1,025 62.4
Minnesota 2 20.8 (20.3, 21.3) 36 (30, 41) 1,396 57.1
Michigan 2 21.7 (21.3, 22.1) 30 (24, 34) 2,709 60.8
Massachusetts 2 17.9 (17.5, 18.3) 50 (47, 51) 1,533 57.2
Maryland 2 21.2 (20.7, 21.7) 32 (27, 38) 1,551 60.4
Maine 2 20.8 (19.9, 21.8) 35 (24, 45) 400 58.4
Louisiana 7 25.6 (24.9, 26.2) 6 (4, 10) 1,385 57.5
Kentucky 7 27.0 (26.4, 27.6) 3 (2, 5) 1,466 58.0
Kansas 2 24.4 (23.7, 25.2) 10 (5, 18) 828 61.7
Iowa 7 23.3 (22.6, 24.0) 19 (10, 26) 901 57.3
Indiana 2 24.9 (24.4, 25.4) 9 (5, 13) 1,977 62.8
Illinois 7 24.1 (23.7, 24.4) 13 (9, 17) 3,664 61.6
Idaho 7 22.1 (21.2, 23.1) 26 (16, 36) 466 62.4
Hawaii 7 21.9 (21.0, 23.0) 29 (17, 38) 411 57.5
Georgia 7 23.6 (23.2, 24.0) 16 (10, 21) 2,811 59.3
Florida 2 22.2 (22.0, 22.5) 25 (21, 29) 6,653 60.7
District of Columbia 2 19.2 (17.7, 20.8) 46 (31, 51) 126 53.1
Delaware 2 20.4 (19.3, 21.6) 37 (26, 48) 266 60.8
Connecticut 7 19.3 (18.7, 19.9) 45 (39, 49) 881 55.7
Colorado 2 19.7 (19.2, 20.2) 43 (37, 47) 1,246 63.2
California 7 19.1 (18.9, 19.3) 47 (43, 49) 8,449 55.8
Arkansas 2 25.7 (25.0, 26.5) 4 (3, 10) 945 60.7
Arizona 2 19.3 (18.9, 19.7) 44 (40, 48) 1,710 59.9
Alaska 2 25.2 (23.5, 26.9) 8 (2, 23) 185 61.7
Alabama 2 22.0 (21.4, 22.5) 28 (20, 33) 1,355 54.4

Notes:
Created by statecancerprofiles.cancer.gov on 03/30/2026 11:06 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top